EDAP EDAP TMS SA

EDAP TMS S.A. First Quarter 2004 Meets Expectations - Improved Revenues and Restructured Costs Deliver Results - VAULX-EN-VELIN, France, April 19 /PRNewswire-FirstCall/ -- EDAP TMS S.A. , a global leader in the development, marketing and distribution of a portfolio of minimally-invasive medical devices for the treatment of urological diseases, ahead of the release of its first quarter 2004 financial results on May 12, 2004, today announced progress on its expectations. The Company's expectations of the first quarter were based on double digit percentage revenue growth, sustained gross margins and significant expense reductions, versus same quarter a year ago, with the aim of operating income or break-even in each of the two operating divisions. Full first quarter 2004 financial results will be released, as previously announced, on May 12, 2004, followed by a conference call on May 13, 2004. EDAP TMS S.A. is the global leader in the development, production, marketing and distribution of a portfolio of minimally invasive medical devices primarily for the treatment of urological diseases. The Company currently develops and markets devices for the minimally invasive treatment of localized prostate cancer, using High Intensity Focused Ultrasound (HIFU), through its EDAP SA subsidiary; it is also developing this technology for the treatment of certain other types of tumors. EDAP TMS S.A. also produces and commercializes medical equipment for treatment of urinary tract stones using Extra-corporeal Shockwave Lithotripsy (ESWL), via its TMS SA subsidiary. In addition, the Company markets in Japan and Italy devices for the non-surgical treatment of benign Prostate Hyperplasia (BPH) using Microwave Thermotherapy (TUMT). For more information, in the U.S., contact EDAP Technomed Inc., the Company's U.S. subsidiary located in Atlanta, GA, by phone at (770) 446-9950. For additional information on the Company, please see the Company's web site at: http://www.edap-tms.com/. This press release contains, in addition to historical information, forward-looking statements that involve risks and uncertainties. These include statements regarding the Company's growth and expansion plans. Such statements are based on management's current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that may cause such a difference include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission. CONTACT: Philippe Chauveau / Blandine Confort 33.4.72.15.31.50 Ian Vawter - EDAP Technomed Inc. 1.770.446.9950 DATASOURCE: EDAP TMS S.A. CONTACT: Philippe Chauveau or Blandine Confort, +33-4-72-15-31-50, both for EDAP TMS S.A.; or Ian Vawter - EDAP Technomed Inc., +1-770-446-9950 Web site: http://www.edap-tms.com/

Copyright